Abstract
From a holistic point of view, aging results from the cumulative erosion of the various systems. Among these, the immune system is interconnected to the rest as immune cells are present in all organs and recirculate through bloodstream. Immunosenescence is the term used to define the remodelling of immune changes during aging. Because immune cells—and particularly lymphocytes—can further differentiate after their maturation in response to pathogen recognition, it is therefore unclear when senescence is induced in these cells. Additionally, it is also unclear which signals triggers senescence in immune cells (i) aging per se, (ii) specific response to pathogens, (iii) underlying conditions, or (iv) inflammaging. In this review, we will cover the current knowledge and concepts linked to immunosenescence and we focus this review on lymphocytes and T cells, which represent the typical model for replicative senescence. With the evidence presented, we propose to disentangle the senescence of immune cells from chronological aging.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
The interest in aging studies has grown with the number of elderly individuals in our societies. There is the opportunity to increase health span by better understanding the process of aging and why disease becomes more prevalent. Early studies on aging humans revealed the reduced capacity of leukocytes to produce certain cytokines or to proliferate in response to in vitro stimulation [1] and, thus, emerged the concept of immunosenescence, which is coined for the age-related immune erosion. While a significant number of studies focused on lymphocytes are particularly T cells, there are older theories that innate immunity may have a preponderant implication in the process and signs of aging [2]. Immunosenescence is often pointed to explain the reduce responsiveness to vaccination in older adults. However, not all elderly show hypo-responsiveness towards vaccination and some older adults are able to maintain a fully functional immune system during old age. This then poses an essential question: what is immunosenescence and when does it apply? In this review, we will cover the global changes observed in the major organ system with a focus on the immune system. We will cover the most updated findings in the field and propose why and how we should better redefine immunosenescence.
Aging of the major organ system
Aging differentially affects the human body, with studies suggesting that different organs and even regions within the same organ can change at different rates (Fig. 1) [3]. Therefore, even if our body and the individual organ systems are of the same chronological age, we should be more focused on measuring our “biological age”, which tracks the detrimental effect of time on each of our organs, especially because these effects vary between individuals [4]. Regardless, there are some important structural and functional changes that occur in the major organs system that we will briefly cover in this section.
Brain aging
One major organ system associated with aging is our brain and central nervous system. Aging is associated with a shrinkage in brain volume, although the exact cause of this decrease is not definitively known [5]. The prevailing theories for this observation are neuronal cell death and/or a reduction in neuronal volume [6]. In addition, changes in the neuronal structure have also been described, such as synaptic pruning [6], dendritic sprouting [7], and deterioration of the myelin sheath, which can then affect cognition [8]. Different areas of the brain exhibit different rates of shrinkage at different ages [9]. A longitudinal study found that the cross-sectional whole brain, temporal lobe, and hippocampus volumes decreased with age, with an accelerated atrophy rate after 70 years of age [9]. Multiple cross-sectional studies were also reviewed, and the authors concluded that the prefrontal cortex was the most affected area of the brain with age [10]. In addition to a decreased brain volume, aging also brings about cognitive decline and pathological diseases. Aging adversely affects the brain vasculature, and the altered blood-brain barrier and reduced cerebral blood flow are associated with white matter lesions, and correspondingly with cognitive decline [11,12,13]. Hypertension and altered small and large cerebro-vasculature are also associated with stroke and Alzheimer’s disease [12,13,14]. From an immunological perspective, the aged brain experiences an increase in an inflammatory phenotype. One key cell population proposed to contribute to the inflammation in the brain is the microglia. Microglia is an innate immune cell of the central nervous system, and in aged mouse studies, is primed for increased activation and expression of increased markers of inflammation. Following the theory that increased inflammation in the brain contributes to cognitive decline, cytokines such as type 1 IFN have been shown to negatively impact brain function [15] while IL-4 is pro-cognitive in mice [16]. In human studies, peripheral blood CD28− CD4 T cells has been shown to expand in Alzheimer’s patients compared with healthy control, contributing to low-grade inflammation [17]. Thus, an increased pro-inflammatory phenotype in the central nervous system could be associated with cognitive impairment, which can exacerbate any cognitive degeneration due to age-associated structural changes [18].
Musculoskeletal aging
Another system often associated with aging is the musculoskeletal system. Aging brings about a deterioration of the structural integrity of the supporting skeletal structure as well as the muscles that determine our mobility, strength, and frailty. Bones are complex structures consisting of a collection of minerals, organic matrix, vasculature, and cells that grow and change in composition over one’s lifetime [19]. There is an increased risk of fracture with age caused by multiple factors such as increased brittleness due to changes in bone mineral density [20] and protein matrix [21, 22], structural weakening due to morphological changes [23], and an imbalance in bone formation, resorption, and bone repair [19].
Muscles work together with the skeletal structure to facilitate motion and mobility. Sarcopenia is defined as the decline in muscle mass and function and is one of the most significant changes caused by age that influences frailty, which is a syndrome as described by Fried and colleagues that collectively includes weakness, weight loss, low physical activity, exhaustion, and slowness [24, 25]. This decrease in muscle strength and function is due to quantitative and qualitative changes in the muscle fibres and motor unit [26]. At the muscle level, there is a loss in overall muscle fibres due to an imbalance of muscle regrowth and protein synthesis, although the exact mechanism for this decline is still under investigation and is influenced by both biological and lifestyle factors [26]. There is also a particular decrease of fast myosin isoform-expressing fibres compared with slow myosin isoform-expressing fibres, thus possibly decreasing the maximum force generated [27]. In addition, the lost fibres can be replaced by non-contractile connective or fat tissue, thus reducing the overall muscle strength even though cross-sectional area of the muscle is unchanged [28, 29]. Apart from the muscle itself, studies have implicated that loss of muscle function is linked to the age-related changes and loss of motor neurons in the motor unit. With aging, motor neurons start experiencing irregularities that adversely affect their ability to transmit signals and to restore synapses to muscle fibres after injury. Ultimately, these motor neurons, especially the largest and fastest conducting ones, are lost due to cell death [26]. One leading theory for this loss is the accumulation of DNA damage and modifications as a possible result of reactive oxygen species (ROS) generation [30]. Thus, both muscle strength and fine muscle control decline with age.
The immune system is also associated directly and indirectly with the age-associated muscle decline. Multiple immune cells (macrophages, eosinophils, and Tregs) have been implicated in appropriate muscle repair and regeneration (Fig. 2). Of special note are Tregs as they are important in the repair of injured muscle by controlling the local inflammatory responses and promoting muscle growth by releasing growth factors. There is a reduction of Treg accumulation in injured muscles of aged mice, with an associated reduction of muscle repair. This observation can be reversed by treatment with IL-33 which induces an increased Treg population and an associated enhancement of muscle repair [31, 32]. Other immune system related cytokines, such as C-reactive protein, IL-6, and TNF-α, are associated with sarcopenia which is unsurprising as they have been implicated in protein synthesis and proteolysis. As it turns out, these cytokines also tend to be upregulated in the elderly [33].
Thankfully, this age-related decline of muscle function can be ameliorated to some extent with interventions such as exercise and caloric restriction [26, 34]. Reduced muscle function also contributes to one aging-related change in the next major organ that we shall discuss.
Lung aging
The lungs are also associated with pathology in aging. As one of the organ systems constantly exposed to external stresses and allergens, the lungs play an important function as a physical as well as immunological barrier to the environment (Fig. 3). As a consequence of age-associated muscular degeneration, respiratory muscle strength is affected, leading to difficulties in breathing and reduced cough strength [35, 36]. The inability to adequately expel air, fluids, and particles from the airways is particularly detrimental during infection and disease. This is compounded by the reduced ability of the cilia lining the upper and lower airway to efficiently work to move foreign particles and mucus up and out of the airways [37]. Structurally, there is an increase in average alveolus size and decrease in alveolus elasticity, and this affects the efficiency of air exchange and susceptibility for alveolar damage during infections [38, 39].
As the lungs are one of the external facing organs, this also brings us to another important factor: the effect of aging on the immune system. After exposure to environmental allergens or infections, the immune system has to mount a delicately balanced response to the challenge to avoid lasting damage from the allergen/infectious agent or from the body’s own immune response. The immune response in aged organisms is often inappropriate, such as the innate cell response of increased pulmonary neutrophilia in the lung after exposure to cigarette smoke and increasing the risk of chronic obstructive pulmonary diseases (COPD) [40]. In the context of influenza infection, this increase in pulmonary neutrophilia is contributed by a combination of excessive neutrophil recruitment by aged alveolar epithelial cells (AECs) and an impairment of alveolar macrophage phagocytosis of apoptotic neutrophils as demonstrated by the Goldstein group in an aged murine model [41, 42]. In addition to this innate response dysfunction, the adaptive immune system also undergoes significant age-related changes. The decreased capacity for dendritic cells (DCs) to properly home and present antigens to B and T cells [43], along with the decreased naïve T cell compartment and B cell antibody-secretion capability [44, 45], mean that the adaptive immune system is less able to efficiently respond to novel infections in aged people. These inappropriate immune responses can then contribute to excessive tissue damage, reduced tissue repair, or ineffective infection clearance and therefore lead to reduced lung function [35]. Further discussion on the effects of aging on the immune system will be discussed in more details later in this review.
Gastrointestinal aging
The gastrointestinal system is another major system that has an extensive interaction with the external environment. Of all the systems mentioned thus far, it is the most complex to study because its health and aged physiology is intrinsically linked to the microbiome contained within. There is a general consensus that with age, the microbiome changes, with community-dwelling elderly exhibiting more discrete and nursing home elderly exhibiting more drastic changes. Nonetheless, with age, the gut microbiome exhibits decreased microbial diversity as well as pathobiont overgrowth throughout the gastrointestinal tract [46, 47]. The changes in the microbiome have extensive physiological and biological effects on the gut environment as well as on the whole organism [47]. Indeed, there are many various gastrointestinal dysfunction and disorders associated with old age such as loss of intestinal barrier integrity, reduced gut motility, colitis, ulcers, cancers, and internal haemorrhage [48]. Of particular note for this review is how gut dysbiosis can trigger inflammatory responses in an organism. One study demonstrated how a microbiome transplant from aged to young mice caused local and systemic inflammatory responses in the recipients, suggesting that gut dysbiosis can drive chronic inflammation and lead to an inflammaging phenotype [49].
However, studies on the human gut have to take into account whether their observations are intrinsically linked to age, to changes in the microbiota, or both. Many of the disorders mentioned above are associated with old age but are not definitely linked to the process of aging per se. In addition, there are many other studies that observed conflicting results; for example, some animal studies reported a decline in myenteric neurons with age [50], while others reported no significant changes [51, 52]. Whether this is also observed in humans has yet to be proven. This is especially true given that human aging is influenced by the complex interplay of genetic, environmental, societal, and infection factors, thus making studying aging in the gut a particularly difficult challenge. However, if it is true that some gastrointestinal disorders are caused by changes in the microbial milieu and not by age, then careful application of prebiotics and probiotics may prove to be effective prophylactic or therapeutic treatments [47]. This may then reduce the incidence of inflammaging and age-related diseases and could be exploited as a method of ameliorating the “aging” phenotype observed in the gut.
Cardiovascular aging
The last system that we will briefly discuss is the cardiovascular system. Much like the central nervous system, it links all the other organ systems together, transporting blood and metabolites, and can thus affect all other organ systems. In addition, blood is an easy tissue to acquire and analyse as a proxy for the overall health of the organism. The heart is at the literal heart of the cardiovascular system, and cardiac aging is associated with a change in cardiac structure. As with many other organ systems, aging leads to cell loss, in this case of cardiomyocytes and sinoatrial pacemaker cells [53, 54]. This loss corresponds with deposition of extracellular matrix, causing fibrosis and a decrease in the strength and elasticity of the cardiac walls. This change drives further adaptive remodelling of the heart structure, causing ventricular and arterial hypertrophies [53]. Together, these remodelling changes drastically modify the proper muscular and electrical functions of the heart, increasing the risks of arrhythmia and heart failure. This extracellular matrix remodelling is also observed in the vascular periphery, causing arterial stiffening and endothelial dysfunction, which increases the risk of hypertension, ischemia, stroke, and heart disease [55]. Like many other organs, apart from structural changes in the heart itself, aging also causes changes to the immune system in the heart; much like other organ systems, the heart also exhibits chronic inflammation. CD4 T cell and macrophages have been suggested as key players involved in inflammation in the heart tissue. One study showed that in aged mice, mediastinal lymph node CD4 T cells mediated increased inflammatory signals in the heart as they exhibited a stronger type 1 immune response as well as increased c-met-mediated homing to the heart tissue [56]. Macrophages have also been implicated in contributing to the inflammatory phenotype as there is an increased number of macrophages as well as macrophage-associated pro-inflammatory cytokines such as MMP-9 and CCL2 in the heart tissue [57].
With this brief overview of key structural and functional changes in multiple organ systems, one striking commonality is a decrease in cell number and cell quality, a gradual change in tissue organisation within each organ system over time, and an increase in chronic inflammation. One important general mechanism proposed for aging is the downregulation of autophagy and mitophagy in aged individuals [58, 59]. This allows damaged cells, which could display a senescence associated secretory phenotype (SASP) to persist, accumulating more DNA and cellular damage, ROS, and oxidative stress, but remains uncleared from the organism; SASP induces chronic inflammation, which has a widespread deleterious effect that is linked to the aging phenotype observed in multiple organ systems [60]. However, the mechanism behind the decreased autophagy in the elderly is yet to be fully elucidated.
Senescence of the immune system
The term immunosenescence is now often used to describe collective changes that are observed within the immune system with age. This term “immunosenescence” has gained a negative reputation in the literature over the past decades due to its association with an increased susceptibility towards to infections, cancer, dementia, cardiovascular diseases, hypertension, diabetes, and autoimmune diseases [61,62,63,64,65,66]. Alterations in the age-dependent behaviour of T cells, natural killer (NK) cells, B cells, monocytes, and neutrophils have all been implicated in the characterization of immunosenescence [67]. While associated with chronological age, the development of immunosenescence in individuals is sensitive to environmental cues, such as immunological and infection history; it is therefore necessary to consider both influences to appreciate the diverse manifestations of immunosenescence that is observed between individuals of the same age [68].
Among different immune cell types, T cell in aging has been most meticulously characterized and includes the loss of proliferative capacity with progressive replication cycles that accelerate telomeric erosion and the accumulation of DNA damage. Senescent T cells, defined by their loss of replicative capacity, display the downregulated expression of CD27 and CD28 and can be distinguished by the elevated expression of CD57, KLRG-1, Tim-3, and CD45RA [69]. Senescent T cells are prolific producers of IL-6, IL-8, TNF, IFNγ, IL-10, and TGF-β but unable to proliferate effectively when stimulated [70]. In addition to these intrinsic properties, T cell senescence can also be described at the systemic level—this is the result of a progressive loss of lymphocyte renewal capacity through thymic involution or reduced hematopoiesis with age [71]. The latter mechanisms impede naïve cell renewal and contribute to a T cell compartment where fewer clones of late-differentiated T cells predominate [72]. Besides the accumulation of senescent T cells, naïve T cells defined by the expression of CD27 and CD45RA have been shown to be dysfunctional with age [73, 74]. However, this could be due to the purity of naïve T cells being isolated in those studies as recent studies have demonstrated that naïve T cells remain functional and it is the virtual memory (in mice), human memory T cells with naïve phenotype, and T memory stem cells that are dysfunctional during aging [75,76,77,78,79]. With respect to B cells, an age-associated decline in clonal diversity, the efficiency of the antibody response, and the frequencies of naïve and total B cells in peripheral blood have also been described [80].
While the study of immunosenescence has conventionally focused on lymphocyte behaviour, the expanding literature on age-associated changes in innate immune cells has allowed us to extend the usage of this term to describe functional adaptations in macrophages, neutrophils, dendritic cells, and NK cells with age [67]. For example, macrophages and neutrophils from the elderly exhibit diminished capacities for phagocytosis and chemotaxis [81, 82]. In aged mice, macrophages were more polarized towards an M2 anti-inflammatory phenotype that biased IL-10 versus IL-12 and TNF-α secretion [83]. With age, NK cells display a loss of proliferative capacity, cytotoxicity, as well as cytokine and chemokine productivity [84].
Given this perception of an age-dependent loss of function across multiple immune cell subtypes, it can be difficult to perceive immunosenescence as an adaptation rather than a consequence of aging. However, these age-associated mechanisms may have co-evolved to minimize disruption to immunological function that may accompany aging. For example, inflammaging—a systemic state of chronic low-grade inflammation that becomes more apparent with age—may reduce the threshold required for the activation of immune cells that is required for competent immunosurveillance. The observation of a heightened risk of infections in novel therapies that neutralize inflammatory molecules, such as IL-6 and TNF-α, supports the latter hypothesis and suggests that these strategies could disrupt immune homeostasis during aging [85, 86]. Therefore, studies on the aging immune system should look towards unravelling productive interactions during immunosenescence, as a broader insight of immunosenescence is necessary to facilitate anti-aging therapies—following sections discuss how we can redefine immunosenescence for this purpose.
Rethinking Immunosenescence
Factors influencing immune aging
Aging has been associated with a myriad of both acute and chronic diseases. At the core of these diseases, the change in the host immune system with age could either have contributed to the cause as it is the host main defence mechanism against foreign pathogens or its functionality being impacted by these diseases and conditions. These includes chronic infections such as CMV, HIV and malaria, chronic stress and glucocorticoids, memory dysfunction, bipolar disorder, and chronic inflammation that are due to immunosenescence or accelerates it [87,88,89,90,91,92,93,94,95]. However, the change in the immune system with age could also be seen as an adaptation process to save resources for the host rather than it being detrimental. This is because developing competent naïve T cells has only about 1–2% success rate due to the various stringent selection processes. Therefore, biological processes such as thymic involution could be seen as advantageous to the host from an energetic or evolutionary point of view [96,97,98]. One of the main arguments that thymic involution is detrimental to the host is due to the reduction of naïve T cells being produced, leading to a narrower repertoire for new antigens and perhaps reduced vaccine efficacy often observed in the elderly [98], while this may have been a successful programmed process for the shorter-lived humans in the past centuries and before the extended human lifespan has revealed the probable need to reverse this adaptation.
Reduced vaccine efficacy has often been observed in the elderly ever since the development of vaccines which has saved many lives from infectious diseases [99, 100]. However, recent studies have suggested that reduced vaccine efficacy is not limited to elderly individuals. Obese individuals have been reported to have reduced vaccine efficacy or impact following secondary re-challenge after vaccination even in the young [101,102,103,104]. In the elderly, studies have also shown that chronic stress, dementia, and malnutrition also have a significant impact on the efficacy of vaccination [105,106,107,108]. On the flip side, boosting of vaccine efficacy in the elderly seems possible as studies involving mTOR inhibitor such as analogs of rapamycin were able to mildly increase vaccine efficacy in the elderly [109, 110]. Metformin (a proposed drug for anti-aging) has also been included in a clinical trial to assess its potential to boost vaccine efficacy in the elderly [111]. Collectively, these studies indicate that other physiological factors are also important considerations in order for a successful vaccination to occur besides the range of T cell repertoire in the host.
The contribution of inflammaging
Chronic low-grade inflammation is a commonality between individuals that exhibit chronic stress, obesity, aging, sleep loss, gut dysbiosis, CMV infection, dysregulated immune cell functions, and accumulation of SASP cells such as fibroblasts [112,113,114,115,116,117]. Studies have shown that chronic stress is able to induce increased levels of CRP, IL-6, TNF-α, and IL-1b [118, 119]. This is very much similar to obesity, in particular visceral fats and aging [120,121,122,123,124,125,126]. Chronic low-grade inflammation is defined as a higher baseline of pro-inflammatory cytokines in the circulation though the source and specific cytokines might differ slightly between these “diseases” in the absence of foreign pathogen infection. In terms of impaired immunity, both human and animal studies have shown that chronic stress reduces various immune functional capacities such as antibody production, virus-specific T cell and NK cell activities, and also the proliferation of leukocytes [127,128,129,130].
As for obesity that is also highly associated with other metabolic syndromes such as diabetes, it has been shown that insulin resistance may lead to insufficient T cell activation and also the resolution of inflammation post infection due to lack of TH2 differentiation. Besides insulin resistance, adipokines such as leptin and adiponectin are also seen to be reduced in individuals with obesity and metabolic syndromes and both play a role in initiating immune responses and resolution of inflammation respectively [131]. In response to infection, obese individuals have been reported to have a worse outcome of infection to 2009 influenza A H1N1 pandemic strain and circulating mononuclear cells exhibits a more pro-inflammatory state compared with healthy individuals [132].
In aging studies, for T cells, highly differentiated T cells, which have lower proliferation capacity, have been shown to accumulate in high frequencies and reduced productions of IL-2 in naïve T cells are some of the examples that render the T cell compartment dysfunctional in elderly individuals. As for the innate immunity compartment, macrophage phagocytic functions are reduced; neutrophil chemotaxis ability in response to infection and CD16 expression are reduced [87].
Collectively, these highlight that the presence of impaired immunity albeit having slight differences in the different scenarios and low-grade chronic inflammation could be the underlying factors that exacerbate pathology in various disease contexts.
Immunosenescence is not age-dependent
Thus, it is important that we redefine and stress that the definition of immunosenescence is the dysfunctionality of the immune system and should encompass some features of low-grade chronic inflammation. Though this phenomenon is often seen in aged individuals, it is also possible in younger adults as it could be “accelerated immunosenescence”, especially for T cells, as shown in CMV and HIV seropositive young patients [72, 133]. Even early in life, the impact of CMV can be observed. The study from Miles et al. showed the rapid and sustained switch of the naïve/memory T cell ratio in 1-year-old infants seropositive for CMV compared with age-matched seronegative infants. Up to one-third of the pool of CD8+ T cells could exhibit loss of CD28 and CD27, which represents the profile of terminal effector T cells, many of which are in a replicative senescence stage [134]. This highlights that other factors other than chronological age could determine this level of senescence of the immune system, especially for T cells which are prone to proliferation. Looking at the other extreme, a recent study analysed the individual-level changes in the immune system profile over a 9-year period. Despite the inter-individual variability in the rates of change of some of the immune cell proportions, the authors defined an immune aging (IMM-AGE) that describes the immune status better than chronological age. This IMM-AGE score could predict all-cause mortality and could be associated to individuals with cardiovascular diseases [135]. While some aspects of immunosenescence could be associated to aging, evidence strongly suggest that responses to stressors (infectious or not) are strong modulators of this process. The concept of “accelerated biological aging” is also shown in two studies that compared biological age and chronological age in an individual, and they were able to show that individuals that have older “biological age”, as compared with chronological age, exhibit cognitive decline, looked older, self-reported worse health, and measuring lifespan (mortality) and health span (frailty) [136, 137]. Whether this is affected by the overall immunological history—the number of pathogen one experience during lifespan—is a plausible hypothesis that warrants further work. Overall, rethinking the causing agents and implications of immunosenescence will help shift the perspective that this phenomenon is not attributed to age alone, especially with the global rising rate of obesity and chronic stress of modern-day life in the young [138,139,140,141].
Immune cell function: differentiation, adaptation, or senescence?
Post-maturation differentiation
The immune system consists of many types of different immune cells that can be generally classified into innate and adaptive. While the immune cells in the innate immune systems generally are differentiated into its respective cell populations before exiting the bone marrow, the immune cells in the adaptive immune systems such as the classical B and T cells will require further immunological processes such as antigen presentation and undergo differentiation before being able to exert its effector functions. The differentiation stages of T cells can be identified using surface markers such as CD27 and CD45RA (or CD45RO, inversely expressed) into naïve (CD27+ CD45RA+), central memory (CD27+ CD45RA−), effector memory (CD27− CD45RA−), and terminal effector (CD27− CD45RA+), and each subset has its own define functional role in the immune system. Naïve T cells are able to proliferate effectively but not able to produce cytokines such as IFNγ while central memory T cells are able to secrete IFNγ but not effector molecules such as TNF-α. Effector memory T cells are able to secrete effector molecules, and terminal effector T cells are able to secrete a wider range of cytokines but have limited proliferative capacity. [142].
B cell differentiation stages, on the other hand, can be identified using surface markers such as CD27 and IgD into naïve (CD27− IgD+), memory B cells (CD27+ IgD+), switched memory (CD27+ IgD−), and double negative (CD27− IgD−) [143]. In general, the various immune cells undergo a linear differentiation process to achieve its various effector functions. However, there is also a certain level of plasticity for certain cell types such as ILCs and macrophages due to the environmental milieu that could alter its function, which should also be viewed as adaption [144, 145].
Post-differentiation adaptation
Adaptation by definition is a process, whereby the subject changes certain aspects of itself to better survive in the current environment. Thus, the end goal of the process would be an evolutionary stronger organism being emerged after the current situation but only for that particular situation [146]. With this, we can view that a functional immune system should be a system that is adaptable throughout the host lifetime as its role is to protect the host from various foreign pathogens during that timeframe. Various adaptation processes of the immune system when encountered with foreign pathogens can be seen in the different immune cells ranging from innate immune cells (e.g. monocytes and natural killer cells) to adaptive immune cells (e.g. T cells and B cells).
The term innate describes the ability to perform a function by an organism as naturally inherited and not due to improvement based on the current situation which will otherwise be termed as adaptive. Thus, innate immune cells are termed as such because its effector functions do not require additional process for it to be functional in times of challenge and its magnitude of the effector function following secondary challenge does not differ as they do not possess immunological memory. However, recent studies with regard to trained immunity on monocytes and “memory” natural killer cells suggest that they might possess a certain level of adaptation or immunological memory though it could be short-lived as compared with the classical T and B cells which are long-lived. “Trained” monocytes have been shown to secrete higher level of pro-inflammatory cytokines following a second challenge by a different stimulant. After the first challenge, genes associated with pro-inflammatory cytokines are marked with H3K4m1 and H3K27ac, a signature of an open chromatin, allowing these genes to be more transcribed easily [147,148,149]. Even though this process has been shown to only last for up to 3 months, trained immunity can be seen as an adaptation process by the monocytes as it primes itself to react stronger to another challenge by a similar or different stimulus [150]. This process could therefore be seen as essential as the immune system could deem the current environment as dangerous that threatens the survival of the host.
Natural killer cells have been traditionally categorized as innate in the lymphoid compartment as they do not under RAG recombination and possess immunological memory [151]. However, recent studies in have shown that NKs could have a “bystander effect”, similar to the concept of trained immunity, whereby it has enhanced responses for if they were exposed to IL-12 and IL-18 prior to the second challenge in mice and “immunological memory” that leads to clonal expansion upon antigenic challenge [152,153,154]. These two processes thus illustrate how NKs could help the immune system to adapt to the current environment that could then enhance the survival rate of the host.
Adaptation of differentiated immune cells
For adaptive immune cells such as T cells and B cells, differentiation is a required process for it to exert its function during foreign pathogen infections. This is observed when a naïve T cell or memory T cell differentiates into an effector cell and clonally expand during such situation. Thus, differentiation could also be seen as an adaption process by the adaptive immune system to combat the current infection. Following resolution of the infection, some of the remaining T cells differentiates into central memory, effector memory, and also tissue-resident memory T cells [155], while B cells differentiate into memory B cells and secrete antibodies in the circulation. This post-infection differentiation process is part of the adaption that allows these immune cells to respond more efficiently when challenged with the same pathogen. Altogether, this makes the organism “fitter” in the local environment, whereby the host is expected to face the same pathogen again [156].
Senescence: the end road of adaptation
However, with the constant adaptation that is needed to ensure that the host survive, there is perhaps a limit to the adaptation process as resources could be limited. This might result in some immune cells exhibiting a replicative senescence phenotype, whereby they lose their proliferation capacity. The accumulation of such replicative senescent T and NK cells is often observed in individuals with chronic viral infections such as CMV, HIV, and also elderly individuals [134, 157,158,159,160]. This phenomenon of replicative senescent was first demonstrated by Hayflick and is also known as the Hayflick Limit, whereby the cells could not replicate due to the shortening of its telomere with each cell replication [161]. For most cell types, when they become senescent, there is a maintenance system that they are either removed by immune cells or undergo apoptosis and the functionality of this system is essential to prevent impaired immunity [162, 163]. However, this is not the same for T cells, as senescent CD8 T cells are capable to acquire a broad-spectrum, innate-like killing activity through NKG2D against viral infected cells and tumour [164, 165], suggesting that it could be a benefit to keep senescent T cells in the circulation considering that thymic involution occurs which results in the reduction of producing new competent naïve T cells. Therefore, this process could then be seen as an adaptation even though not optimal to combat past infections faced by the host in order to prevent re-activation of chronic infection.
Conclusion
The immune system is required to go through a continuous adaptive process throughout the host lifetime, constantly changing and remodeling to ensure the host survival in an environment littered with foreign pathogens. Differentiation, trained immunity, immunological memory, and perhaps senescence are some of the mechanisms it utilizes for this adaption process to balance the use of limited resources and the survival of the host. When studying immunity in the context of aging, it is important to differentiate these processes to better translate the findings into effective measure for improving immune response in older adults. In the era of omics, the contribution of epigenetic studies would be important to define the actual age of cells we study [166]. An important factor related to immunogerontological studies is cellular turnover which varies significantly between cell types. Another important factor is replicative capacity. While some cell types such as T cells are able to proliferate (as part of their function), others proliferate much less (e.g. monocytes) and as such are less susceptible to replicative senescence. While we use cellular markers, especially by flow cytometry, to identify cell types and subtypes, we still do not understand the reason these markers are up- or downregulated. Further studies on the role of changed expression would unravel whether this is part of differentiation or an adaptation to specific stimuli. Two markers in particular are of interest in the context of T cells: (i) CD57, probably the best marker of replicative senescence, for which we still do not know the ligand and the intracellular interactome and signaling effect, and (ii) CD45, a phosphatase involved in T cell receptor signaling but which splicing variants (CD45RA, CD45RB, CD45RO) have not been investigated enough for their differential expression and signaling. Why a vast majority of replicative senescent T cells (CD57+) express CD45RA is not known. The complexity also resides in the fact senescence is not linked to one type of stimuli and that several signaling pathways may lead to senescence in the same cell type. Defining the commonalities in the process of senescence across various immune and non-immune cells would help answer some of these questions which could then be utilized to improve health span.
References
Gillis S, Kozak R, Durante M, Weksler ME (1981) Immunological studies of aging. Decreased production of and response to T cell growth factor by lymphocytes from aged humans. J Clin Invest. https://doi.org/10.1172/JCI110143
Metchnikoff E, Mitchell PC (1907) The prolongation of life: optimistic studies. Editor: Peter Chalmers Mitchell
Cole JH, Marioni RE, Harris SE, Deary IJ (2019) Brain age and other bodily ‘ages’: implications for neuropsychiatry. Mol Psychiatry 24(2):266–281. https://doi.org/10.1038/s41380-018-0098-1
Han JDJ, Xia X, Chen W, McDermott J Molecular and phenotypic biomarkers of aging. F1000Research 6. Faculty of 1000 Ltd, 2017. https://doi.org/10.12688/f1000research.10692.1
Peters R (2006) Ageing and the brain. Postgrad Med J 82(964):84–88. https://doi.org/10.1136/pgmj.2005.036665
Anderton BH (2002) Ageing of the brain. Mech Ageing Dev. https://doi.org/10.1016/S0047-6374(01)00426-2
Kolb B, Whishaw IQ (1998) Brain plasticity and behavior. Annu Rev Psychol. https://doi.org/10.1146/annurev.psych.49.1.43
Kövari E et al (2004) Cortical microinfarcts and demyelination significantly affect cognition in brain aging. Stroke. https://doi.org/10.1161/01.STR.0000110791.51378.4E
Scahill RI, Frost C, Jenkins R, Whitwell JL, Rossor MN, Fox NC (2003) A longitudinal study of brain volume changes in normal aging using serial registered magnetic resonance imaging. Arch Neurol. https://doi.org/10.1001/archneur.60.7.989
Raz N (2004) Aging brain: structural changes and their implications for cognitive aging - Oxford Scholarship. In: Dixon R, Backman L, Nilsson L-G (eds) New frontiers in cognitive aging. Oxford University Press, Oxford, pp 115–134
Marstrand JR et al (2002) Cerebral perfusion and cerebrovascular reactivity are reduced in white matter hyperintensities. Stroke. https://doi.org/10.1161/01.STR.0000012808.81667.4B
Jellinger KA (2002) Alzheimer disease and cerebrovascular pathology: an update. J Neural Transm. https://doi.org/10.1007/s007020200068
Petkov CI et al (2004) Correlates of memory function in community-dwelling elderly: the importance of white matter hyperintensities. J Int Neuropsychol Soc. https://doi.org/10.1017/S1355617704103056
Elias MF et al (2004) Framingham stroke risk profile and lowered cognitive performance. Stroke. https://doi.org/10.1161/01.STR.0000103141.82869.77
Baruch K, Deczkowska A, David E, Castellano JM, Miller O, Kertser A, Berkutzki T, Barnett-Itzhaki Z, Bezalel D, Wyss-Coray T, Amit I, Schwartz M (2014) Aging. Aging-induced type I interferon response at the choroid plexus negatively affects brain function. Science (New York, N.Y.) 346(6205):89–93. https://doi.org/10.1126/science.1252945
Kipnis J, Gadani S, Derecki NC (2012) Pro-cognitive properties of T cells. Nat Rev Immunol 12(9):663–669. https://doi.org/10.1038/nri3280
Larbi A, Pawelec G, Witkowski JM, Schipper HM, Derhovanessian E, Goldeck D, Fulop T (2009) Dramatic shifts in circulating CD4 but not CD8 T cell subsets in mild Alzheimer’s disease. J Alzheimers Dis 17(1):91–103. https://doi.org/10.3233/JAD-2009-1015
Norden DM, Godbout JP (2014) Microglia of the aged brain: primed to be activated and resistant to regulation. Neuropathol Appl Neurobiol 39(1):19–34. https://doi.org/10.1111/j.1365-2990.2012.01306.x.Microglia
Boskey AL, Coleman R (2010) Critical reviews in oral biology & medicine: aging and bone. J Dent Res 89(12):1333–1348. https://doi.org/10.1177/0022034510377791
Currey JD, Brear K, Zioupos P (1996) The effects of ageing and changes in mineral content in degrading the toughness of human femora. J Biomech. https://doi.org/10.1016/0021-9290(95)00048-8
Bailey AJ, Sims TJ, Ebbesen EN, Mansell JP, Thomsen JS, Mosekilde L (1999) Age-related changes in the biochemical properties of human cancellous bone collagen: relationship to bone strength. Calcif Tissue Int. https://doi.org/10.1007/s002239900683
Nyman JS et al (2006) Age-related effect on the concentration of collagen crosslinks in human osteonal and interstitial bone tissue. Bone. https://doi.org/10.1016/j.bone.2006.06.026
Tommasini SM, Nasser P, Schaffler MB, Jepsen KJ (2005) Relationship between bone morphology and bone quality in male tibias: implications for stress fracture risk. J Bone Miner Res. https://doi.org/10.1359/JBMR.050326
Ophet Veld LPM, van Rossum E, Kempen GIJM et al (2015) Fried phenotype of frailty: cross-sectional comparison of three frailty stages on various health domains. BMC Geriatr 15:77. https://doi.org/10.1186/s12877-015-0078-0
Cesari M, Landi F, Vellas B, Bernabei R, Marzetti E (2014) Sarcopenia and physical frailty: two sides of the same coin. Front Aging Neurosci. https://doi.org/10.3389/fnagi.2014.00192
Larsson L et al (2019) Sarcopenia: aging-related loss of muscle mass and function. Physiol Rev. https://doi.org/10.1152/physrev.00061.2017
Brocca L et al (2017) Structure and function of human muscle fibres and muscle proteome in physically active older men. J Physiol. https://doi.org/10.1113/JP274148
Visser M et al (2005) Muscle mass, muscle strength, and muscle fat infiltration as predictors of incident mobility limitations in well-functioning older persons. J Gerontol Ser A Biol Sci Med Sci. https://doi.org/10.1093/gerona/60.3.324
Buch A et al (2016) Muscle function and fat content in relation to sarcopenia, obesity and frailty of old age — an overview. Exp Gerontol. https://doi.org/10.1016/j.exger.2016.01.008
De Waard MC et al (2010) Age-related motor neuron degeneration in DNA repair-deficient Ercc1 mice. Acta Neuropathol. https://doi.org/10.1007/s00401-010-0715-9
Burzyn D, Kuswanto W, Kolodin D, Shadrach JL, Cerletti M, Jang Y, Sefik E, Tan TG, Wagers AJ, Benoist C et al (2013) A special population of regulatory T cells potentiates muscle repair. Cell 155:1282–1295
Castiglioni A, Corna G, Rigamonti E, Basso V, Vezzoli M, Monno A, Almada AE, Mondino A, Wagers AJ, Manfredi AA et al (2015) FOXP3+ T cells recruited to sites of sterile skeletal muscle injury regulate the fate of satellite cells and guide effective tissue regeneration. PLoS One 10:e0128094
Wang J, Leung KS, Chow SKH, Cheung WH (2017) Inflammation and age-associated skeletal muscle deterioration (sarcopaenia). J Orthop Transl 10:94–101. https://doi.org/10.1016/j.jot.2017.05.006
Shinpo K, Kikuchi S, Sasaki H, Ogata A, Moriwaka F, Tashiro K (2000) Selective vulnerability of spinal motor neurons to reactive dicarbonyl compounds, intermediate products of glycation, in vitro: implication of inefficient glutathione system in spinal motor neurons. Brain Res. https://doi.org/10.1016/S0006-8993(00)02047-3
Lowery EM, Brubaker AL, Kuhlmann E, Kovacs EJ (2013) The aging lung. Clin Interv Aging 8:1489–1496. https://doi.org/10.2147/CIA.S51152
Kim J, Davenport P, Sapienza C (2009) Effect of expiratory muscle strength training on elderly cough function. Arch Gerontol Geriatr. https://doi.org/10.1016/j.archger.2008.03.006
Svartengren M, Falk R, Philipson K (2005) Long-term clearance from small airways decreases with age. Eur Respir J. https://doi.org/10.1183/09031936.05.00002105
Bowdish DME (2019) The aging lung: is lung health good health for older adults? Chest 155(2):391–400. https://doi.org/10.1016/j.chest.2018.09.003
Meiners S, Eickelberg O, Königshoff M (2015) Hallmarks of the ageing lung. Eur Respir J. https://doi.org/10.1183/09031936.00186914
Liu J et al (2017) J Immunol Res:2017. https://doi.org/10.1155/2017/6710278
Kulkarni U et al (2019) Excessive neutrophil levels in the lung underlie the age-associated increase in influenza mortality. Mucosal Immunol 12(2):545–554
Wong CK et al (2017) Aging impairs alveolar macrophage phagocytosis and increases influenza-induced mortality in mice. J Immunol 199(3):1060–1068
Zhao J, Zhao J, Legge K, Perlman S (2011) Age-related increases in PGD 2 expression impair respiratory DC migration, resulting in diminished T cell responses upon respiratory virus infection in mice. J Clin Invest. https://doi.org/10.1172/JCI59777
Provinciali M, Moresi R, Donnini A, Lisa RM (2009) Reference values for CD4+ and CD8+ T lymphocytes with naïve or memory phenotype and their association with mortality in the elderly. Gerontology. https://doi.org/10.1159/000199451
Weksler ME (2000) Changes in the B-cell repertoire with age. Vaccine. https://doi.org/10.1016/S0264-410X(99)00497-1
Mangiola F, Nicoletti A, Gasbarrini A, Ponziani FR (2018) Gut microbiota and aging. Eur Rev Med Pharmacol Sci 22(21):7404–7413. https://doi.org/10.26355/eurrev-201811-16280
Nagpal R et al (2018) Gut microbiome and aging: physiological and mechanistic insights. Nutr Healthy Aging. https://doi.org/10.3233/NHA-170030
Dumic I, Nordin T, Jecmenica M, Stojkovic Lalosevic M, Milosavljevic T, Milovanovic T (2019) Gastrointestinal tract disorders in older age. Can J Gastroenterol Hepatol:2019. https://doi.org/10.1155/2019/6757524
Fransen F et al (2017) Aged gut microbiota contributes to systemical inflammaging after transfer to germ-free mice. Front Immunol 8(NOV):1–12. https://doi.org/10.3389/fimmu.2017.01385
Saffrey MJ (2013) Cellular changes in the enteric nervous system during ageing. Dev Biol. https://doi.org/10.1016/j.ydbio.2013.03.015
Van Ginneken C, Schäfer KH, Van Dam D, Huygelen V, De Deyn PP (2011) Morphological changes in the enteric nervous system of aging and APP23 transgenic mice. Brain Res. https://doi.org/10.1016/j.brainres.2011.01.030
Gamage PP, Ranson RN, Patel BA, Yeoman MS, Saffrey MJ (2013) Myenteric neuron numbers are maintained in aging mouse distal colon. Neurogastroenterol Motil. https://doi.org/10.1111/nmo.12114
Steenman M, Lande G (2017) Cardiac aging and heart disease in humans. Biophys Rev. https://doi.org/10.1007/s12551-017-0255-9
Keller KM, Howlett SE (2016) Sex differences in the biology and pathology of the aging heart. Can J Cardiol. https://doi.org/10.1016/j.cjca.2016.03.017
Xu X et al (2017) Recent progress in vascular aging: mechanisms and its role in age-related diseases. Aging Dis. https://doi.org/10.14336/AD.2017.0507
Ramosa GC et al (2017) Myocardial aging as a T-cell-mediated phenomenon. Proc Natl Acad Sci U S A 114(12):E2420–E2429. https://doi.org/10.1073/pnas.1621047114
Ma Y, Mouton AJ, Lindsey ML (2018) Cardiac macrophage biology in the steady-state heart, the aging heart, and following myocardial infarction. Transl Res. https://doi.org/10.1016/j.trsl.2017.10.001
Barbosa MC, Grosso RA, Fader CM (2019) Hallmarks of aging: an autophagic perspective. Front Endocrinol. https://doi.org/10.3389/fendo.2018.00790
Diot A, Morten K, Poulton J (2016) Mitophagy plays a central role in mitochondrial ageing. Mamm Genome 27(7–8):381–395. https://doi.org/10.1007/s00335-016-9651-x
Ohtani N (2019) Deciphering the mechanism for induction of senescence-associated secretory phenotype (SASP) and its role in ageing and cancer development. J Biochem 166(4):289–295. https://doi.org/10.1093/jb/mvz055
El Chakhtoura NG, Bonomo RA, Jump RLP (2017) Influence of aging and environment on presentation of infection in older adults. Infect Dis Clin North Am. https://doi.org/10.1016/j.idc.2017.07.017
Gavazzi G, Krause KH (2002) Ageing and infection. Lancet Infect Dis. https://doi.org/10.1016/S1473-3099(02)00437-1
Zinger A, Cho WC, Ben-Yehuda A (2017) Cancer and aging - the inflammatory connection. Aging Dis. https://doi.org/10.14336/AD.2016.1230
Brayne C, Miller B (2017) Dementia and aging populations—a global priority for contextualized research and health policy. PLoS Med. https://doi.org/10.1371/journal.pmed.1002275
Rodgers JL et al (2019) Cardiovascular risks associated with gender and aging. J Cardiovasc Dev Dis. https://doi.org/10.3390/jcdd6020019
Thewissen M, Stinissen P (2008) New concepts on the pathogenesis of autoimmune diseases: a role for immune homeostasis, immunoregulation, and immunosenescence. Crit Rev Immunol. https://doi.org/10.1615/critrevimmunol.v28.i5.10
Maijó M, Clements SJ, Ivory K, Nicoletti C, Carding SR (2014) Nutrition, diet and immunosenescence. Mech Ageing Dev. https://doi.org/10.1016/j.mad.2013.12.003
Koch S et al (2007) Cytomegalovirus infection: a driving force in human T cell immunosenescence. In: Annals of the New York Academy of Sciences. https://doi.org/10.1196/annals.1396.043
Zhao Y, Shao Q, Peng G (2020) Exhaustion and senescence: two crucial dysfunctional states of T cells in the tumor microenvironment. Cell Mol Immunol. https://doi.org/10.1038/s41423-019-0344-8
Weyand CM, Yang Z, Goronzy JJ (2014) T-cell aging in rheumatoid arthritis. Curr Opin Rheumatol. https://doi.org/10.1097/BOR.0000000000000011
Malaguarnera L et al (2001) Immunosenescence: a review. Arch Gerontol Geriatr 32(1):1–14. https://doi.org/10.1016/S0167-4943(00)00086-8
Tu W, Rao S (2016) Mechanisms underlying T cell immunosenescence: aging and cytomegalovirus infection. Front Microbiol. https://doi.org/10.3389/fmicb.2016.02111
Goronzy JJ, Fang F, Cavanagh MM, Qi Q, Weyand CM (2015) Naive T cell maintenance and function in human aging. J Immunol (Baltimore, Md. : 1950) 194(9):4073–4080. https://doi.org/10.4049/jimmunol.1500046
Salam N, Rane S, Das R, Faulkner M, Gund R, Kandpal U, Lewis V, Mattoo H, Prabhu S, Ranganathan V, Durdik J, George A, Rath S, Bal V (2013) T cell ageing: effects of age on development, survival & function. Indian J Med Res 138(5):595–608
Chiu BC et al (2013) Cutting edge: central memory CD8 T cells in aged mice are virtual memory cells. J Immunol 191(12):5793–5796
Renkema KR et al (2014) Two separate defects affecting true naive or virtual memory T cell precursors combine to reduce naive T cell responses with aging. J Immunol 192(1):151–159
Lanzer KG et al (2018) Virtual memory cells make a major contribution to the response of aged influenza-naive mice to influenza virus infection. Immun Ageing 15:17
Pulko V, Davies JS, Martinez C, Lanteri MC, Busch MP, Diamond MS, Knox K, Bush EC, Sims PA, Sinari S, Billheimer D, Haddad EK, Murray KO, Wertheimer AM, Nikolich-Žugich J (2016) Human memory T cells with a naive phenotype accumulate with aging and respond to persistent viruses. Nat Immunol 17(8):966–975. https://doi.org/10.1038/ni.3483
Kared H, Tan SW, Lau MC et al (2020) Immunological history governs human stem cell memory CD4 heterogeneity via the Wnt signaling pathway. Nat Commun 11:821. https://doi.org/10.1038/s41467-020-14442-6
Buffa S et al (2011) B cell immunosenescence: different features of naive and memory B cells in elderly. In: Biogerontology. https://doi.org/10.1007/s10522-011-9353-4
Linehan E, Fitzgerald D (2015) Ageing and the immune system: focus on macrophages. Eur J Microbiol Immunol. https://doi.org/10.1556/eujmi-d-14-00035
Butcher SK et al (2001) Senescence in innate immune responses: reduced neutrophil phagocytic capacity and CD16 expression in elderly humans. J Leukoc Biol. https://doi.org/10.1189/jlb.70.6.881
Oishi Y, Manabe I (2016) Macrophages in age-related chronic inflammatory diseases. npj Aging Mech Dis. https://doi.org/10.1038/npjamd.2016.18
Camous X, Pera A, Solana R, Larbi A (2012) NK cells in healthy aging and age-associated diseases. J Biomed Biotechnol. https://doi.org/10.1155/2012/195956
Campbell L, Chen C, Bhagat SS, Parker RA, Östör AJK (2011) Risk of adverse events including serious infections in rheumatoid arthritis patients treated with tocilizumab: a systematic literature review and meta-analysis of randomized controlled trials. Rheumatology. https://doi.org/10.1093/rheumatology/keq343
Cacciapaglia F, Navarini L, Menna P, Salvatorelli E, Minotti G, Afeltra A (2011) Cardiovascular safety of anti-TNF-alpha therapies: facts and unsettled issues. Autoimmun Rev. https://doi.org/10.1016/j.autrev.2011.04.014
Ventura MT, Casciaro M, Gangemi S, Buquicchio R (2017) Immunosenescence in aging: between immune cells depletion and cytokines up-regulation. Clin Mol Allergy. https://doi.org/10.1186/s12948-017-0077-0
Gruver AL, Hudson LL, Sempowski GD (2007) Immunosenescence of ageing. J Pathol. https://doi.org/10.1002/path.2104
Koch S, Larbi A, Ozcelik D, Solana R, Gouttefangeas C, Attig S, Wikby A, Strindhall J, Franceschi C, Pawelec G (2007) Cytomegalovirus infection: a driving force in human T cell immunosenescence. Ann N Y Acad Sci 1114:23–35
Frimpong A, Kusi KA, Adu-Gyasi D, Amponsah J, Ofori MF, Ndifon W (2019) Phenotypic evidence of T cell exhaustion and senescence during symptomatic Plasmodium falciparum malaria. Front Immunol 10:1345. https://doi.org/10.3389/fimmu.2019.01345
Bauer ME (2005) Stress, glucocorticoids and ageing of the immune system. Stress (Amsterdam, Netherlands) 8(1):69–83. https://doi.org/10.1080/10253890500100240
Petersen LE, Grassi-Oliveira R, Siara T, dos Santos SG, Ilha M, de Nardi T, Keisermann M, Bauer ME (2015) Premature immunosenescence is associated with memory dysfunction in rheumatoid arthritis. Neuroimmunomodulation 22(3):130–137. https://doi.org/10.1159/000358437
Petersen LE, Baptista T, Molina JK, Motta JG, do Prado A, Piovesan DM, de Nardi T, Viola TW, Vieira É, Teixeira AL, Grassi-Oliveira R, Bauer ME (2018) Cognitive impairment in rheumatoid arthritis: role of lymphocyte subsets, cytokines and neurotrophic factors. Clin Rheumatol 37(5):1171–1181. https://doi.org/10.1007/s10067-018-3990-9
do Prado CH, Rizzo LB, Wieck A, Lopes RP, Teixeira AL, Grassi-Oliveira R, Bauer ME (2013) Reduced regulatory T cells are associated with higher levels of Th1/TH17 cytokines and activated MAPK in type 1 bipolar disorder. Psychoneuroendocrinology 38(5):667–676. https://doi.org/10.1016/j.psyneuen.2012.08.005
Rizzo LB, Do Prado CH, Grassi-Oliveira R, Wieck A, Correa BL, Teixeira AL, Bauer ME (2013) Immunosenescence is associated with human cytomegalovirus and shortened telomeres in type I bipolar disorder. Bipolar Disord 15:832–838 © 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Shanley DP, Aw D, Manley NR, Palmer DB (2009) An evolutionary perspective on the mechanisms of immunosenescence. Trends Immunol. https://doi.org/10.1016/j.it.2009.05.001
George AJT, Ritter MA (1996) Thymic involution with ageing: obsolescence or good housekeeping? Immunology Today 17(6) Elsevier Ltd:267–272. https://doi.org/10.1016/0167-5699(96)80543-3
Aw D, Palmer DB (2011) The origin and implication of thymic involution. Aging Dis 2011 Oct; 2(5):437–443
Lang PO, Mendes A, Socquet J, Assir N, Govind S, Aspinall R (2012) Effectiveness of influenza vaccine in aging and older adults: comprehensive analysis of the evidence. Clin Interv Aging. https://doi.org/10.2147/CIA.S25215
Lord JM (2013) The effect of aging of the immune system on vaccination responses. Hum Vacc Immunother 9(6) Taylor & Francis:1364–1367. https://doi.org/10.4161/hv.24696
Painter SD, Ovsyannikova IG, Poland GA (2015) The weight of obesity on the human immune response to vaccination. Vaccine. https://doi.org/10.1016/j.vaccine.2015.06.101
Park HL et al (2014) Obesity-induced chronic inflammation is associated with the reduced efficacy of influenza vaccine. Hum Vacc Immunother. https://doi.org/10.4161/hv.28332
Green WD, Beck MA (2017) Obesity impairs the adaptive immune response to influenza virus. Ann Am Thorac Soc. https://doi.org/10.1513/AnnalsATS.201706-447AW
Neidich SD et al (2017) Increased risk of influenza among vaccinated adults who are obese. Int J Obes. https://doi.org/10.1038/ijo.2017.131
Kiecolt-Glaser JK, Glaser R, Gravenstein S, Malarkey WB, Sheridan J (1996) Chronic stress alters the immune response to influenza virus vaccine in older adults. Proc Natl Acad Sci U S A. https://doi.org/10.1073/pnas.93.7.3043
Remarque EJ, Cools HJM, Boere TJ, Van Der Klis RJ, Masurel N, Ligthart GJ (1996) Functional disability and antibody response to influenza vaccine in elderly patients in a Dutch nursing home. Br Med J. https://doi.org/10.1136/bmj.312.7037.1015
Vedhara K (1999) Chronic stress in elderly carers of dementia patients and antibody response to influenza vaccination. Lancet. https://doi.org/10.1016/S0140-6736(98)06098-X
Potter JM, O’Donnell B, Carman WF, Roberts MA, Stott DJ (1999) Serological response to influenza vaccination and nutritional and functional status of patients in geriatric medical long-term care. Age Ageing. https://doi.org/10.1093/ageing/28.2.141
Mannick JB et al (2014) mTOR inhibition improves immune function in the elderly. Sci Transl Med. https://doi.org/10.1126/scitranslmed.3009892
Keating R et al (2013) The kinase mTOR modulates the antibody response to provide cross-protective immunity to lethal infection with influenza virus. Nat Immunol. https://doi.org/10.1038/ni.2741
Vaccination efficacy with metformin in older adults - full text view - ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03996538 (accessed May 05, 2020).
Li H, Weng P, Najarro K, Xue QL, Semba RD, Margolick JB, Leng SX (2014) Chronic CMV infection in older women: longitudinal comparisons of CMV DNA in peripheral monocytes, anti-CMV IgG titers, serum IL-6 levels, and CMV pp65 (NLV)-specific CD8(+) T-cell frequencies with twelve year follow-up. Exp Gerontol 54:84–89. https://doi.org/10.1016/j.exger.2014.01.010
Mullington JM, Simpson NS, Meier-Ewert HK, Haack M (2010) Sleep loss and inflammation. Best practice & research. Clin Endocrinol Metab 24(5):775–784. https://doi.org/10.1016/j.beem.2010.08.014
Lobionda S, Sittipo P, Kwon HY, Lee YK (2019) The role of gut microbiota in intestinal inflammation with respect to diet and extrinsic stressors. Microorganisms 7(8):271. https://doi.org/10.3390/microorganisms7080271
Coppé JP, Desprez PY, Krtolica A, Campisi J (2010) The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol 5:99–118. https://doi.org/10.1146/annurev-pathol-121808-102144
Cevenini E, Monti D, Franceschi C (2013) Inflamm-ageing. Curr Opin Clin Nutr Metab Care 16(1):14–20. https://doi.org/10.1097/MCO.0b013e32835ada13
Furman D, Campisi J, Verdin E, Carrera-Bastos P, Targ S, Franceschi C, Ferrucci L, Gilroy DW, Fasano A, Miller GW, Miller AH, Mantovani A, Weyand CM, Barzilai N, Goronzy JJ, Rando TA, Effros RB, Lucia A, Kleinstreuer N, Slavich GM (2019) Chronic inflammation in the etiology of disease across the life span. Nat Med 25(12):1822–1832. https://doi.org/10.1038/s41591-019-0675-0
Liu YZ, Wang YX, Jiang CL (2017) Inflammation: the common pathway of stress-related diseases. Front Hum Neurosci. https://doi.org/10.3389/fnhum.2017.00316
Miller AH, Maletic V, Raison CL (2009) Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry. https://doi.org/10.1016/j.biopsych.2008.11.029
Monteiro R, Azevedo I (2010) Chronic inflammation in obesity and the metabolic syndrome. Mediators Inflamm. https://doi.org/10.1155/2010/289645
Van Harmelen V et al (2002) Increased lipolysis and decreased leptin production by human omental as compared with subcutaneous preadipocytes. Diabetes. https://doi.org/10.2337/diabetes.51.7.2029
Bertin E, Nguyen P, Guenounou M, Durlach V, Potron G, Leutenegger M (2000) Plasma levels of tumor necrosis factor alpha (TNF-α) are essentially dependent on visceral fat amount in type 2 diabetic patients. Diabetes Metab. 2000 May;26(3):178–82
You T et al (2008) The metabolic syndrome is associated with circulating adipokines in older adults across a wide range of adiposity. J Gerontol Ser A Biol Sci Med Sci. https://doi.org/10.1093/gerona/63.4.414
Ferrucci L, Fabbri E (2018) Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol. https://doi.org/10.1038/s41569-018-0064-2
Ferrucci L et al (2010) Proinflammatory state, hepcidin, and anemia in older persons. Blood. https://doi.org/10.1182/blood-2009-02-201087
Fulop T et al (2018) Immunosenescence and inflamm-aging as two sides of the same coin: friends or foes? Front Immunol. https://doi.org/10.3389/fimmu.2017.01960
Edwards EA, Dean LM (1977) Effects of crowding of mice on humoral antibody formation and protection to lethal antigenic challenge. Psychosom Med. https://doi.org/10.1097/00006842-197701000-00003
Gimsa U, Tuchscherer M, Kanitz E (2018) Psychosocial stress and immunity-what can we learn from pig studies? Front Behav Neurosci 12:64. https://doi.org/10.3389/fnbeh.2018.00064
Morey JN, Boggero IA, Scott AB, Segerstrom SC (2015) Current directions in stress and human immune function. Curr Opin Psychol 5:13–17. https://doi.org/10.1016/j.copsyc.2015.03.007
Segerstrom SC, Miller GE (2004) Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychol Bull 130(4):601–630. https://doi.org/10.1037/0033-2909.130.4.601
Andersen CJ, Murphy KE, Fernandez ML (2016) Impact of obesity and metabolic syndrome on immunity. Adv Nutr. https://doi.org/10.3945/an.115.010207
Milner JJ, Beck MA (2012) The impact of obesity on the immune response to infection. In: Proceedings of the Nutrition Society. https://doi.org/10.1017/S0029665112000158
Deeks SG (2011) HIV infection, inflammation, immunosenescence, and aging. Annu Rev Med. https://doi.org/10.1146/annurev-med-042909-093756
Miles DJC et al (2007) Cytomegalovirus infection in Gambian infants leads to profound CD8 T-cell differentiation. J Virol 81(11):5766–5776. https://doi.org/10.1128/jvi.00052-07
Alpert A et al (2019) A clinically meaningful metric of immune age derived from high-dimensional longitudinal monitoring. Nat Med 25(3):487–495. https://doi.org/10.1038/s41591-019-0381-y
Zhong X et al (2019) Estimating biological age in the Singapore longitudinal aging study. J Gerontol Ser A. https://doi.org/10.1093/gerona/glz146
Belsky DW et al (2015) Quantification of biological aging in young adults. Proc Natl Acad Sci U S A. https://doi.org/10.1073/pnas.1506264112
Hruby A, Hu FB (2015) The epidemiology of obesity: a big picture. Pharmacoeconomics. https://doi.org/10.1007/s40273-014-0243-x
Agha M, Agha R (2017) The rising prevalence of obesity. Int J Surg Oncol 2(7):e17. https://doi.org/10.1097/ij9.0000000000000017
Jackson M (2014) The stress of life: a modern complaint? Lancet. https://doi.org/10.1016/s0140-6736(14)60093-3
DeVries MW, Wilkerson B (2003) Stress, work and mental health: a global perspective. In: Acta Neuropsychiatrica. https://doi.org/10.1034/j.1601-5215.2003.00017.x
Xu W, Larbi A (2017) Markers of T cell senescence in humans. Int J Mol Sci. https://doi.org/10.3390/ijms18081742
Wei C, Jung J, Sanz I (2011) OMIP-003: phenotypic analysis of human memory B cells. Cytometry A. https://doi.org/10.1002/cyto.a.21112
Colonna M (2018) Innate lymphoid cells: diversity, plasticity, and unique functions in immunity. Immunity. https://doi.org/10.1016/j.immuni.2018.05.013
Shapouri-Moghaddam A et al (2018) Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol. https://doi.org/10.1002/jcp.26429
Gardner A (2017) The purpose of adaptation. Interface Focus. https://doi.org/10.1098/rsfs.2017.0005
Van Der Heijden CDCC, Noz MP, Joosten LAB, Netea MG, Riksen NP, Keating ST (2018) Epigenetics and trained immunity. Antioxid Redox Signal. https://doi.org/10.1089/ars.2017.7310
Netea MG et al (2016) Trained immunity: a program of innate immune memory in health and disease. Science. https://doi.org/10.1126/science.aaf1098
van Splunter M et al (2018) Induction of trained innate immunity in human monocytes by bovine milk and milk-derived immunoglobulin G. Nutrients. https://doi.org/10.3390/nu10101378
Kleinnijenhuis J et al (2012) Bacille Calmette-Guérin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes. Proc Natl Acad Sci U S A. https://doi.org/10.1073/pnas.1202870109
Paust S, Von Andrian UH (2011) Natural killer cell memory. Nat Immunol. https://doi.org/10.1038/ni.2032
Sun JC, Lanier LL (2018) Is there natural killer cell memory and can it be harnessed by vaccination?: NK cell memory and immunization strategies against infectious diseases and cancer. Cold Spring Harb Perspect Biol. https://doi.org/10.1101/cshperspect.a029538
Nikzad R et al (2019) Human natural killer cells mediate adaptive immunity to viral antigens. Sci Immunol. https://doi.org/10.1126/sciimmunol.aat8116
Geary CD, Sun JC (2017) Memory responses of natural killer cells. Semin Immunol. https://doi.org/10.1016/j.smim.2017.08.012
Farber DL, Yudanin NA, Restifo NP (2014) Human memory T cells: generation, compartmentalization and homeostasis. Nat Rev Immunol. https://doi.org/10.1038/nri3567
Ratajczak W, Niedźwiedzka-Rystwej P, Tokarz-Deptuła B, DeptuŁa W (2018) Immunological memory cells. Cent Eur J Immunol. https://doi.org/10.5114/ceji.2018.77390
Vasto S, Colonna-Romano G, Larbi A et al (2007) Role of persistent CMV infection in configuring T cell immunity in the elderly. Immun Ageing 4:2. https://doi.org/10.1186/1742-4933-4-2
Solana R, Alonso MC, Peña J (1999) Natural killer cells in healthy aging. Exp Gerontol 34(3):435–443. https://doi.org/10.1016/s0531-5565(99)00008-x
Hayhoe RP, Henson SM, Akbar AN, Palmer DB (2010) Variation of human natural killer cell phenotypes with age: identification of a unique KLRG1-negative subset. Hum Immunol 71(7):676–681
Zhang Y, Wallace DL, de Lara CM, Ghattas H, Asquith B, Worth A, Griffin GE, Taylor GP, Tough DF, Beverley PC, Macallan DC (2007) In vivo kinetics of human natural killer cells: the effects of ageing and acute and chronic viral infection. Immunology 121(2):258–265. https://doi.org/10.1111/j.1365-2567.2007.02573.x
Shay JW, Wright WE (2000) Hayflick, his limit, and cellular ageing. Nat Rev Mol Cell Biol. https://doi.org/10.1038/35036093
Palacio L et al (2019) Restored immune cell functions upon clearance of senescence in the irradiated splenic environment. Aging Cell. https://doi.org/10.1111/acel.12971
Ovadya Y et al (2018) Impaired immune surveillance accelerates accumulation of senescent cells and aging. Nat Commun. https://doi.org/10.1038/s41467-018-07825-3
Hu J, Batth IS, Xia X, Li S (2016) Regulation of NKG2D+CD8+ T-cell-mediated antitumor immune surveillance: identification of a novel CD28 activation-mediated, STAT3 phosphorylation-dependent mechanism. Oncoimmunology 5(12):e1252012. https://doi.org/10.1080/2162402X.2016.1252012
Pereira BI, De Maeyer R, Covre LP, Nehar-Belaid D, Lanna A, Ward S, Marches R, Chambers ES, Gomes D, Riddell NE, Maini MK, Teixeira VH, Janes SM, Gilroy DW, Larbi A, Mabbott NA, Ucar D, Kuchel GA, Henson SM, Strid J et al (2020) Sestrins induce natural killer function in senescent-like CD8+ T cells. Nat Immunol 21(6):684–694. https://doi.org/10.1038/s41590-020-0643-3
Xu W et al (2019) Mapping of γ/δ T cells reveals Vδ2+ T cells resistance to senescence. EBioMedicine 39:44–58. https://doi.org/10.1016/j.ebiom.2018.11.053
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
This article is a contribution to the special issue on Immunosenescence: New Biomedical Perspectives - Guest Editors: Claudio Franceschi, Aurelia Santoro, and Miriam Capri
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Xu, W., Wong, G., Hwang, Y.Y. et al. The untwining of immunosenescence and aging. Semin Immunopathol 42, 559–572 (2020). https://doi.org/10.1007/s00281-020-00824-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00281-020-00824-x